BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25702281)

  • 1. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
    Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
    Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of AFP-negative early-stage hepatocellular carcinoma using Fuc-PON1.
    Shu H; Li W; Shang S; Qin X; Zhang S; Liu Y
    Discov Med; 2017 Mar; 23(126):163-168. PubMed ID: 28472609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
    Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.
    Shang S; Qin X; Li W; Zhang S; Liu Y
    Discov Med; 2016 Jan; 21(113):15-23. PubMed ID: 26896598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid diagnosis of hepatocellular carcinoma using a haptoglobin ELISA assay based on AAL-coated magnetic beads.
    Shang S; Sun L; Li W; Qin X; Zhang S; Liu Y
    Discov Med; 2016 Sep; 22(120):97-104. PubMed ID: 27755965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases.
    Jiang K; Shang S; Li W; Guo K; Qin X; Zhang S; Liu Y
    Glycoconj J; 2015 Dec; 32(9):657-64. PubMed ID: 26342810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
    Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of serum paraoxonase/arylesterase 1 and antithrombin-III is a promising non-invasion biomarker for discrimination of AFP-negative HCC versus liver cirrhosis patients.
    Cao X; Cao Z; Ou C; Zhang L; Chen Y; Li Y; Zhu B; Shu H
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101583. PubMed ID: 33756265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.
    Comunale MA; Wang M; Rodemich-Betesh L; Hafner J; Lamontagne A; Klein A; Marrero J; Di Bisceglie AM; Gish R; Block T; Mehta A
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1222-9. PubMed ID: 21467232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases.
    Li L; Gu X; Fang M; Ji J; Yi C; Gao C
    Clin Chem Lab Med; 2016 Apr; 54(4):693-701. PubMed ID: 26035113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
    Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
    Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
    Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
    Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
    Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
    Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
    Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma nuclear factor kappa B and serum peroxiredoxin 3 in early diagnosis of hepatocellular carcinoma.
    Ismail S; Mayah W; Battia HE; Gaballah H; Jiman-Fatani A; Hamouda H; Afifi MA; Elmashad N; Saadany SE
    Asian Pac J Cancer Prev; 2015; 16(4):1657-63. PubMed ID: 25743848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of serum DSA-TRF in hepatocellular carcinoma.
    Guan W; Gao Z; Huang C; Fang M; Feng H; Chen S; Wang M; Zhou J; Hong S; Gao C
    Glycoconj J; 2020 Apr; 37(2):231-240. PubMed ID: 31933068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.